Review: Smokeless Tobacco Linked to Increased Risk of T2DM

Share this content:
Review: Smokeless Tobacco Linked to Increased Risk of T2DM
Review: Smokeless Tobacco Linked to Increased Risk of T2DM

WEDNESDAY, Feb. 8, 2017 (HealthDay News) -- Consumption of Swedish smokeless tobacco (snus) is associated with increased risk of type 2 diabetes, according to a study published online Feb. 6 in the Journal of Internal Medicine.

Sofia Carlsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues used pooled data from five cohorts to examine the correlation between snus use and risk of type 2 diabetes. Data were included from five pooled cohorts for 54,531 never-smoking men and 2,441 incident cases of type 2 diabetes.

The researchers found the hazard ratio for type 2 diabetes to be 1.15 (95 percent confidence interval, 1.00 to 1.32) in current snus users compared with never users. The hazard ratios were 1.42 (95 percent confidence interval, 1.07 to 1.87) and 1.68 (95 percent confidence interval, 1.17 to 2.41), respectively, for individuals consuming five to six and seven or more boxes per week. The hazard ratio was 1.08 (95 percent confidence interval, 1.01 to 1.16) for each additional box of snus consumed per week.

"Our findings indicate that high consumption of snus is a risk factor for type 2 diabetes. The risk was similar to that in smokers, implying that smokers will not reduce their risk of type 2 diabetes by changing to snus use," the authors write. "The results also support the notion that nicotine increases the risk of type 2 diabetes."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »